Blood is defined as entire human blood that has been obtained from a donor and processed for transfusion or further production. Blood component refers to a therapeutic component of human blood, including its red, white, platelet, and plasma cells. The blood and blood components market consist of sales of blood and blood component. The market involves the collection of donor's blood and segregating it into required components for the purpose of therapy. The main types of products in blood and blood components are whole blood and blood components. Human blood from a typical blood donation is known as whole blood. It is utilized in the treatment of excessive bleeding, exchange transfusions, and self-donation of blood. The different blood components include red blood cells, platelets, plasma, and white blood cells and are used in anemia, trauma and surgery, cancer treatment, and bleeding disorders. The several end-users involved are hospitals, ambulatory surgical centres, and others. The blood and blood components market research report is one of a series of new reports from The Business Research Company that provides blood and blood components market statistics, including blood and blood components industry global market size, regional shares, competitors with a blood and blood components market share, detailed blood and blood components market segments, market trends and opportunities, and any further data you may need to thrive in the blood and blood components industry. This blood and blood components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global blood and blood components market size will grow from $37.49 billion in 2022 to $39.21 billion in 2023 at a compound annual growth rate (CAGR) of 4.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global blood and blood components market size is expected to grow to $47.53 billion in 2027 at a CAGR of 4.9%. The blood and blood components market is being driven by increasing incidence of trauma and road accidents. Sometimes, because of traumas such as hemorrhage, the volume of blood is reduced to a very low level and cannot be replaced fast enough by the body. Also, road accidents cause excessive blood loss from the body that has to be restored immediately. At times, the blood itself lacks a few components as in the case of hemophilia. All these conditions demand transfusion of blood and blood components into the patient's body. The growing prevalence of diseases and increasing numbers of road accidents and traumas are increasing the demand for blood and thus driving the market. According to a report by Centres for Disease Control and Prevention, Hemophilia A affects one out of every 5,000 male babies born. Every year, about 400 newborns are born with haemophilia. Also, according to the Arizona Department of Health Services, in 2021, trauma related deaths increased by 19% as compared to 2020. Falls accounted for most deaths and injuries. The blood and blood components market is restrained by the growing risk of developing or transferring an infection while the blood is transmitted to the patients. The growing possibilities of developing any transfusion transmitted infection (TTI) is imposing a restriction on the growth of the market. The fear of transfusion of diseases from the donor to the recipient, forces many customers to avoid using donated blood, thus hampering the growth of the blood and blood components market. The most common viral agents that can be transmitted through blood transfusion are Human Immunodeficiency Virus (HIV), hepatitis viruses, West Nile Virus (WNV), Human T-cell Lymphotrophic Viruses (HTLVs). The most prominent trend that has been witnessed in the blood and blood components market is the growing number of collaborations between the players involved in the market. Companies are adopting partnerships and collaborations in order to expand their reach, increase customer base and generate awareness in the market. For example, the American Red Cross collaborated with HealthStream with an aim of introducing new program for healthcare organizations. Similarly, the BloodCenter of Wisconsin collaborated with SysLogic Inc., to study how the RFID technology can be used to enhance safety of the patient while collecting and transfusing blood products. The blood and blood components market in European Union is governed by Directive 2002/98/EC of the EU regulations. The regulatory body engages itself in providing guidelines and setting standards for quality and safety of collection, testing, processing, storage, and distribution of blood and blood components. These guidelines ensure greater quality and safety of whole blood and its components to prevent transmission of diseases and also highlight necessary measures for their collection and distribution. In October 2022, Pfizer, a US-based pharmaceutical company, acquired Global Blood Therapeutics for an undisclosed amount. The acquisition will strengthen Pfizer's capabilities in treating sickle cell disease while preserving the company's 30-year legacy.Global Blood Therapeutics is a US-based developer of treatments related to blood diseases, especially sickle cell disease.  Major players in the blood and blood components market are the American Red Cross, Australian Red Cross Blood Service, Abbott Laboratories, Blood Centres of America, Becton, Dickinson & Co., German Red Cross, Nipro Medical Corporation, American Association of Blood Banks, AVIS National, and National Blood Authority Australia. North America was the largest region in the blood and blood components market in 2022. Western Europe was the second largest region in the global blood and blood components market. The regions covered in the global blood and blood components market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the blood and blood components market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The blood and blood components market consist of sales of red cells, platelets, plasms, cryoprecipitated AHF, and granulocytes. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global blood and blood components market is segmented - 1) By Product: Whole Blood, Blood Components 2) By End-Users: Hospitals, Ambulatory Surgical Centers, Other End-Users 3) By Application: Anemia, Trauma & Surgery, Cancer Treatment, Bleeding Disorders 4) By Blood Components: Red Blood Cells, Platelets, Plasma, White Blood Cells

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical equipment market is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the market during the forecast period. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical device data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market. The regions covered in the medical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices

Blood transfusion diagnostics are used to conduct tests before the transfusion of blood from donor-recipient such as blood grouping disease screening. The main types of blood transfusion diagnostics are instruments and kits, reagents, and others. The blood transfusion diagnostic kits are used to collect and transfuse blood. The technologies involved in blood transfusion diagnostics are western blot, ELISA, nucleic acid amplification, fluorescence assay, and rapid test that are used for various applications such as blood grouping and disease screening. The end-users involved are hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies. The blood transfusion diagnostics market research report is one of a series of new reports from The Business Research Company that provides blood transfusion diagnostics market statistics, including blood transfusion diagnostics industry global market size, regional shares, competitors with a blood transfusion diagnostics market share, detailed blood transfusion diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the blood transfusion diagnostics industry. This blood transfusion diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global blood transfusion diagnostics market grew from $3.65 billion in 2022 to $3.98 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The blood transfusion diagnostics market is expected to grow from $5.68 billion in 2027 at a CAGR of 9.3%. Patients undergoing surgical procedures need a blood transfusion to replace the lost blood during the procedure. Blood transfusion diagnostics are used during the procedures to screen the blood before transferring it to the patient and will otherwise increase the incidence of infectious disease. According to an article published in the US National Library of Medicine, National Institutes of Health, approximately 310 million surgeries are being performed each year. This increase in the number of procedures will thereby drive the need for blood transfusion diagnostics. Developing and underdeveloped countries lack adequate blood banks, proper medical equipment for blood transfusion, adequate conditions for the storage of blood, and low supply for the high demand of blood. Hospitals are not equipped with proper amenities that help provide hygienic and safe transfusions. For example, according to research conducted by India Spend, around 1.18 million units of blood were wasted during storage in the form of discoloration, bacterial contamination, and expiry due to outdating. The poor infrastructure hampers the growth of the blood transfusion diagnostic market. The growing demand for advanced diagnostic measures and growing prevalence of infectious diseases associated with pathogens such as bacteria & viruses increase the preference for nucleic acid amplification testing (NAAT/NAT) to increase blood safety, improve efficiency and reduce the turnaround time of the results. NAT is a technique that helps detect a particular nucleic acid, virus, or bacteria that acts as a pathogen in blood, tissue, or urine. NAT is highly sensitive and specific for viral nucleic acids and amplifies the region of targeted viral DNA and detects them earlier than the other traditional methods and narrows the period of infectious diseases. For example, XCRP Diagnostic Inc. and Luminex Corporations entered into a licensing agreement of XCR Diagnostic's Xtreme Chain Reaction Nucleic Acid Amplification Technology. In this deal, Luminex got the exclusive rights to use the XCR Diagnostic's NAAT technology for their future molecular diagnostic portfolio. The blood transfusion diagnostics market is highly regulated by governing bodies such as USFDA (the USA Food and Drug Administration), and the Medicines and Healthcare products Agency (MHRA). For instance, the manufacturers and service providers in the USA must comply with the Center for Biologics Evaluation and Research (CBER) Regulations that have been published in the first chapter title 21 of the Code of Federal Regulations (CFR). Part 600 of CFR 21 primarily focuses on the established standards like retention samples conditions, temperature to be maintained during shipment, sterilization of equipment, and role and duties of the inspector to inspect the laboratories. The regulation also allows the manufacturer to report any kind of deviation of their product from their intended purpose. Major players in the blood transfusion diagnostics market are BAG Health Care GmbH, Grifols, Bio-Rad Laboratories Inc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, DiaSorin S.p.A, Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., and Beckman Coulter Inc. North America was the largest region in the blood transfusion diagnostics market in 2022. Western Europe was the second largest region in the global blood transfusion diagnostics market. The regions covered in global blood transfusion diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the blood transfusion diagnostics market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The blood transfusion diagnostics market consists of revenues earned by entities by providing installation and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood transfusion diagnostics market also includes sales of blood transfusion diagnostics devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global blood transfusion diagnostics market is segmented - 1) By Type: Instruments and Kits, Reagents, Other Types 2) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies 3) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test 4) By Application: Blood Grouping, Disease Screening

Blood collection devices are devices used to collect blood samples from the body. Blood collection devices are used for health and wellness testing, population studies, or research and preclinical drug studies. The main types of blood collection devices include blood collection tubes, lancets, micro container tubes, and warming devices. The blood collection tubes refer to tubes used for coagulation investigations and sodium citrate-containing blood collection. Blood collection tubes are used for various components and conduct blood into and out of a patient’s body to get tested in the laboratory. Different tests and biochemical assays require various types of sample collection tubes. The different materials used in the manufacturing of blood collection devices include glass, stainless steel, and plastic. They are used in manual and automatic blood collection by hospitals, blood collection centers, diagnostic centers, and others. The blood collection devices market research report is one of a series of new reports from The Business Research Company that provides blood collection devices market statistics, including blood collection devices industry global market size, regional shares, competitors with a blood collection devices market share, detailed blood collection devices market segments, market trends and opportunities, and any further data you may need to thrive in the blood collection devices industry. This blood collection devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global blood collection devices market size grew from $6.92 billion in 2022 to $7.39 billion in 2023 at a compound annual growth rate (CAGR) of 6.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The blood collection devices market size is expected to grow to $9.59 billion in 2027 at a CAGR of 6.8%. The increase in incidence of infectious diseases is driving the growth of the blood collection devices market. Infectious diseases are infections caused by bacteria, viruses, fungi, or parasites. Infectious disorders such as hepatitis B (HBV), hepatitis C (HCV), the human immunodeficiency virus (HIV), malaria, syphilis, and brucellosis are tested through blood collection and sampling. The constant increase in incidences of infectious diseases and its diagnostics activities are expected to boost the utilization of blood collection devices. According to World Health Organization (WHO), in 2021, an estimated 10.6 million people are infected with tuberculosis globally, 1.6  million died, and 1.5 million people acquired HIV in 2021 while 650,000 people lost lives due to it. Therefore, the increase in incidences of infectious diseases is expected to boost demand for blood collection devices during the forecast period. Technology advancement is a key trend gaining popularity in the blood collection devices market. Many companies operating in the blood collection devices market are developing new products or new technologies to meet fast-growing industry demand and enhance their business presence across the globe. The technologically advanced products developed by companies are focused on enhancing comfort and providing advanced protection to customers. For instance, in April 2022, Owen Mumford, a medical device design and manufacturing company, introduced a new venous blood collection portfolio under its Unistik brand. The new portfolio draws on the company's expertise and history in capillary blood sampling to provide a range of venous devices that ensure patient safety, comfort, and quality. The Unistik ShieldLock Ultra combines a one-handed and in-vein activated safety system to reduce the risk of NSIs. The device also has a unique safety feature that, when activated, closes the tube between the needle and the Luer to avoid blood exposure after the needle is removed from the vein. In July 2021, a leading global medical technology company Becton, Dickinson and Company (BD) acquired Velano Vascular for an undisclosed amount. With this acquisition, BD enables health care providers to help eliminate multiple needlesticks for blood sample collection, reducing the pain and discomfort from the process while delivering quality outcomes and increasing patient satisfaction. Velano Vascular is a US-based medical equipment manufacturer committed to enhancing both inpatient blood collection and vascular access. Major players in the blood collection devices market are Becton, Dickinson and Company, Greiner Group, Kabe Labortechnik GmbH, Sarstedt AG & Company, ICU Medical Inc., Grifols SA, Retractable Technologies Inc., Nipro Corporation, Terumo Corporation, Fresenius Kabi AG, Medtronic, and Radiometer Medical ApS. North America was the largest region in the blood collection devices market in 2022. The Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood collection devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the blood collection devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The blood collection devices market consists of sales of blood collection tubes, needles and syringes, blood bags, blood collection systems, and lancets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global blood collection devices market is segmented - 1) By Type: Blood Collection Tubes, Lancet, Micro Container Tubes, Warming Devices 2) By Method: Manual Blood Collection, Automatic Blood Collection 3) By Material: Glass, Stainless Steel, Plastic 4) By End User: Hospitals, Blood Donation Centers, Diagnostic Center, Other End Users

Patient handling equipment is an assistive device that helps home care and hospital settings for transferring patients between chairs, beds, and other places. They are used for specific lifting, transfer, and movement of patients. The patient handling equipment market covered in this report is segmented by product type into wheelchairs, mobility scooters, medical beds, patient transfer equipment, and others. The patient transfer equipment is used for transferring patients between chairs, beds, and other places. It is also segmented by care type into critical care, fall prevention, bariatric care, and by end-user into homecare, hospitals, and others. The patient handling equipment market research report is one of a series of new reports from The Business Research Company that provides patient handling equipment market statistics, including patient handling equipment industry global market size, regional shares, competitors with a patient handling equipment market share, detailed patient handling equipment market segments, market trends and opportunities, and any further data you may need to thrive in the patient handling equipment industry. This patient handling equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global patient handling equipment market grew from $20.35 billion in 2022 to $21.25 billion in 2023 at a compound annual growth rate (CAGR) of 4.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The patient handling equipment market is expected to grow from $24.62 billion in 2027 at a CAGR of 3.8%. The increasing geriatric population profile of most countries contribute to the growth of the patient handling equipment market. The older population accounts for a higher percentage of hospital admissions owing to the high risk of acquiring chronic and other diseases, thereby generating a higher need for patient handling equipment. According to the World Health Organization, in 2020, there were 1 billion people in the world who were aged 65 years and above. The numer is expected to rise to 1.4 billion by 2030 and 2.1 billion by 2050. Therefore, an increase in the size of the geriatric population is anticipated to boost the demand for the patient handling equipment market during the forecast period. Inconvenience caused by wheelchairs and other patient handling equipment is likely to act as a major restraint for patient handling equipment’s market growth. Physical barriers associated with wheelchairs include inaccessible surroundings, lack of pavements, and climate and physical terrain. For instance, according to the American Nurses Association (ANA), the physical environment can lead to restrictions on the movement and positioning of the patients. This scenario is projected to impact the growth of the patient handling equipment market. The development of smart wheelchairs is a key trend gaining popularity in the patient handling equipment market. A smart wheelchair is a power wheelchair fitted with sensors, cameras, and a computer-based system as the main processing unit, allowing it to handle complex tasks. Major organizations and researchers are concentrating on smart wheelchairs that incorporate sensors and intelligence to reduce the need for human interaction. For instance, in December 2020, Phoenix Instinct, a UK-based mobility equipment company introduced a lightweight wheelchair with a movable axle position that prevents overbalancing by automatically adjusting the chair's center of gravity. The wheelchair is fitted with sensors which detects user movement and direction forward or backward and changes the axle angle to compensate. In March 2021, Direct Healthcare Group, a UK-based medical device company, acquired United Care BV for an undisclosed amount. The acquisition would expand direct healthcare group’s safe moving and handling portfolio and help it better serve the customers. United Care BV is a Netherlands based manufacturer of patient handling solutions. Major players in the patient handling equipment market are ArjoHuntleigh Inc., Hill-Rom Holdings Inc., Invacare Corporation, Stryker Corporation, Drive Divilbiss Healthcare Inc., ETAC AB, Gf Health Products Inc., Guldmann, Inc., Handicare Group AB, and Joerns Healthcare LLC. North America was the largest region in the patient handling equipment market in 2022. Western Europe was the second largest region in the global patient handling equipment market report. The regions covered in the global patient handling equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the patient handling equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The patient handling equipment market consists of sales of accessories, air lateral transfer systems, bed frames, commodes, patient lifts, stretchers, therapy surfaces, and transfer chairs. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global patient handling equipment market is segmented - 1) By Product Type: Wheelchairs, Mobility Scooters, Medical Beds, Patient Transfer Equipment, Other Product Types 2) By Care Type: Critical Care, Fall Prevention, Bariatric Care, Wound Care, Other Care Types 3) By End-User: Biopharmaceutical And Pharmaceutical Companies, Research Institutes, Homecare, Hospitals, Other End-Users

Patient monitoring devices are machines that are used to constantly monitor patients through various vital signs and warning systems to detect and record changes in patient health conditions. The main types of patient monitoring devices market are fetal and neonatal monitoring devices, weight monitoring and body temperature monitoring devices and equipment, vital parameter monitoring devices and equipment, and remote patient monitoring devices and equipment. Fetal and neonatal monitoring devices measure the heart rate and rhythm of the baby (fetus). This lets the healthcare providers see how the baby is doing. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The end-users are hospitals and clinics, diagnostic laboratories, and others. The patient monitoring devices market research report is one of a series of new reports from The Business Research Company that provides patient monitoring devices market statistics, including patient monitoring devices industry global market size, regional shares, competitors with a patient monitoring devices market share, detailed patient monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the patient monitoring devices industry. This patient monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global patient monitoring devices market grew from $23.46 billion in 2022 to $25.53 billion in 2023 at a compound annual growth rate (CAGR) of 8.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The patient monitoring devices market is expected to grow to $34.5 billion in 2027 at a CAGR of 7.8%. The demand for monitoring devices is likely to increase due to the shortage of professionals in the healthcare services industry. According to a report by Mercer, the US requires 2.3 million new healthcare workers by 2025; this includes nurses, physicians, lab technicians, and various other healthcare personnel. This shortage is likely to drive the demand for monitoring systems as these devices allow medical professionals to track multiple patients remotely. This is expected to drive the market for patient monitoring devices in the forecast period. Awareness of diseases is low in many countries across the globe, and this affected the demand for patient monitoring devices in the historic period. For instance, a study conducted by the Indian Council of Medical Research (ICMR) on 213 million people found that only 43.2% are aware of the chronic disease diabetes. This lack of disease awareness limited the diagnosis and treatment pool, thereby restricting market growth for patient monitoring devices. Patient monitoring device manufacturers are offering customized MPMs to cater to the growing patient pool. MPMs monitor different health parameters corresponding to patients’ health conditions. For instance, Infinium Medical’s Omni series monitors are preconfigured with ECG, oxygen saturation, non-invasive blood pressure, and temperature trackers. More advanced health measures such as invasive blood pressure, cardiac output, and anaesthetic agent measurement can be added to this device when needed. Custom MPM is predominantly beneficial for tracking the health status of critically ill patients. Major companies in the patient monitoring devices market include General Electric Company, Koninklijke Philips N.V., Draegerwerk AG, Cardinal Health, Inc., Masimo, Stryker Corporation, Medtronic Inc., Edwards Lifesciences, Flex Ltd., and Nihon Kohden Corporation. Asia-Pacific was the largest region in the global patient monitoring devices market in 2022. North America was the second-largest region in the global patient monitoring devices market. The regions covered in the patient monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the patient monitoring devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The patient monitoring devices market consist of sales of instruments such as blood pressure cuffs, glucometers, pulse oximeter, ECG + stethoscope, wearables (activity trackers and continuous monitoring), and thermometers for patient monitoring. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global patient monitoring devices market is segmented - 1) By Type: Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables Subsegments Covered: Fetal Monitoring Devices, Neonatal Monitoring Devices, Temperature Monitoring Devices, Weight Monitoring Devices, Cardiac Monitoring Devices, Neuromonitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Multiparameter Monitoring Devices, Cardiac Monitors, Respiratory Monitors, Hematological Monitors, Vital Parameter Monitors And Other End Users

Patient portal is an online website service opted for by hospitals that gives patients easy access to health information such as recent doctor visits, prescription refills, medications, discharge summaries, and others. It is used to provide 24/7 access about the healthcare data to the patients. The main types of patient portals are standalone patient portals and integrated patient portals. Integrated patient portals refer to a direct connection to the patient database of a medical facility or organisation and are capable of providing a wide variety of functions and services. The deployment models are on-premise and cloud-based. The various end-users involved are providers, payers, pharmacies, and other end-users. The patient portal market research report is one of a series of new reports from The Business Research Company that provides patient portal market statistics, including patient portal industry global market size, regional shares, competitors with a patient portal market share, detailed patient portal market segments, market trends and opportunities, and any further data you may need to thrive in the patient portal industry. This patient portal market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global patient portal market size grew from $3.63 billion in 2022 to $4.34 billion in 2023 at a compound annual growth rate (CAGR) of 19.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The patient portal market size is expected to grow to $8.78 billion in 2027 at a CAGR of 19.3%. The increase in demand for electronic health records is expected to propel the growth of the patient portal market going forward. The electronic health record refers to a systematic collection of real-time data of patients in digital format by physicians or hospitals, whose information is instantly and securely available by authorised users. Electronic health record (EHR) patient portals provide a means by which patients will access their health information, including diagnostic test results. For instance, in 2021, according to National Coordinator for Health Information Technology (ONC), an entity within the U.S Department of Health and Human Services (HHS) data, approximately 86% of non-Federal general acute care hospitals' physicians have adopted electronic health records to treat patients. Therefore, the increasing demand for electronic health records is driving the growth of the patient portal market. Product innovation is a key trend gaining popularity in the patient portal market. Major companies operating in the patient portal sector are focused on developing new product innovation solutions to strengthen their position. For instance, in 2021, McKesson, a US-based healthcare company that provides patient portals, launched ScriptPASTM, a pharmacy management solution for oncology practises powered by Biologics by McKesson specialty pharmacy. ScriptPASTM is a fee-for-service offering designed to help Medically Integrated Dispensing (MID)-equipped practises provide quicker access to care by reducing barriers that delay treatment. This has been accomplished by providing support with benefits investigation, prior authorization, and financial assistance. In November 2021, Virgin Plus, a Canada-based software and services company operating in healthcare, such as patient portals, acquired Welltok, Inc., for an undisclosed amount. Through this acquisition, Virgin Plus aims to enhance its patient portal platform by integrating Welltok’s personalization and analytics capabilities into home-based health care. Welltok, Inc., is a US-based company operating in designing and developing patient platforms. Major players in the patient portal market are Allscripts Healthcare Solutions Inc., McKesson Corporation, athenahealth Inc., Cerner Corporation, eClinicalWorks, CureMD Healthcare, NextGen Healthcare Information Systems LLC, Greenway Health LLC, Medfusion Inc., Epic Systems Corporation Inc., General Electric (GE) Co. (GE Healthcare), InteliChart, QSI Management LLC, Optum Inc., and ZH Healthcare Inc. North America was the largest region in the patient portal market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient portal market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the patient portal market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The patient portal market consists of sales of open patient portals, closed patient portals, and hybrid portals. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global patient portal market is segmented - 1) By Type: Standalone Patient Portals, Integrated Patient Portals 2) By Deployment Mode: On-Premise, Cloud-Based 3) By End-Users: Providers, Payers, Pharmacies, Other End-Users (Employer Groups and Government Bodies)

Patient registry software refers to a structured system for gathering non-clinical or clinical patient data to evaluate certain outcomes using observational study methodologies. The main types of products in patient registry software are integrated software and standalone software. The various types of databases are disease registries, health service registries, and product registries. The disease registry is used in the state of a particular disease or condition as the inclusion criterion. A disease registry refers to a unique database that includes data on people who have been diagnosed with a certain disease type. The different deployment models include on-premise and cloud-based that involve several functionalities such as population health management, patient care management, medical research and clinical studies, health information exchange, point-of-care, and product outcome evaluation. It is employed by government organizations and third-party administrators, hospitals and medical practices, private payers, pharmaceutical, biotechnology, and medical device companies, and research centers. The patient registry software market research report is one of a series of new reports from The Business Research Company that provides patient registry software market statistics, including patient registry software industry global market size, regional shares, competitors with patient registry software market share, detailed patient registry software market segments, market trends and opportunities, and any further data you may need to thrive in the patient registry software industry. This anomaly detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global patient registry software market size grew from $1.82 billion in 2022 to $2.08 billion in 2023 at a compound annual growth rate (CAGR) of 14.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The patient registry software market size is expected to grow to $3.54 billion in 2027 at a CAGR of 14.2%. The rising adoption of electronic medical records (EMRs) is contributing to the growth of the patient registry software market going forward. An electronic medical record is a digital counterpart of a patient's paper chart. An EMR can help with billing, inter-practice referrals, appointment scheduling, and medication refills. The patient registry software functionality is included as an add-on in EMR and EHR products, thereby promoting the patient registry software market. For instance, in 2021, according to a UK-based intergovernmental organization, the Organization for Economic Co-operation and Development (OECD), 93% of primary care practices across 24 OECD countries use EMRs. Therefore, the rising adoption of electronic medical records will drive the growth of the patient registry software market. Product innovations are the key trends gaining popularity in the patient registry software market. Major companies operating in the patient registry software sector are focused on developing new product innovations to strengthen their position in the market. For instance, In January 2022, Seqster PDM, Inc., a US-based healthcare company that builds comprehensive patient records partnered with the National Pancreas Foundation to develop a registry software that gathers data using remote monitoring devices. The partnership will leverage Seqster's technology, which combines patient information from wearable/remote monitoring devices, genomic DNA tests, and EHR in real-time. The company's platform gathers patient data from various sources, enabling more thorough, coordinated care. The National Pancreatic Cancer Foundation (NPCF) is a nonprofit group providing independent support for those affected by pancreatic cancer. In June 2021, MRO Corp., a US-based software company, acquired FIGmd for an undisclosed amount. With this acquisition, MRO aimed to expand its ability to efficiently acquire, ingest, manage, and exchange clinical information across multiple sources and formats to deliver actionable insights. FIGmd is an India-based software company that assists healthcare companies in measuring, assessing, and enhancing clinical quality data. Major players in the patient registry software market are IFA Systems AG, Imagetrend Inc., IQVIA Holdings Inc., Lumedx Healthcare Technologies Private Limited, M2s Industries Private Limited, Mckesson Corporation, Opentext Corporation, Optum Health & Technology Private Limited, Syneos Health Inc., Phytel Inc., Dacima Software Inc., Evado Clinical Software, Telligen Inc., Global Vision Technology Co. Ltd., Armus Digital Pvt. Ltd., AltaVoice, Gz Technology Pvt. Ltd., Healthmonix, and Premier Inc. North America was the largest region in the patient registry software market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient registry software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the patient registry software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The patient registry software market consists of sales of software and services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global patient registry software market is segmented - 1) By Product: Standalone Software, Integrated Software 2) By Type of Database: Disease Registries, Health Service Registeries, Product Registries 3) By Deployment Model: On-Premise Models, Cloud-Based Models 4) By Functionality: Population Health Management (PHM), Patient Care Management, Health Information Exchange (HIE), Point Of Care, Product Outcome Evaluation, Medical Research And Clinical Studies 5) By End User: Government Organizations And Third-Party Administrators, Hospitals And Medical Practices, Private Payers, Pharmaceutical, Biotechnology, And Medical Device Companies, Research Centers